Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis

Brain Research

Volumn 720, Issue 1-2, 1996, Pages 75-83

  Boje, Kathleen M K ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Aminoguanidine; Blood brain barrier; Blood cerebrospinal fluid barrier; Meningitis; Neurodegeneration; Neuroinflammation; Nitric oxide; Nitric oxide synthase

Indexed keywords

AMINOGUANIDINE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CONTROLLED STUDY; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENINGITIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029980044     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00142-4     Document Type: Article

References (76)

1. Barinaga, M., Antibodies linked to rare epilepsy, Science, 268 (1995) 362-363.
2. Beaven, M.A., Gordon, J.W., Jacobsen S. and Severs, W.B., A specific and sensitive assay for aminoguanidine: Its application to a study of the disposition of aminoguanidine in animal tissues, J. Pharmacol. Exp. Ther., 165 (1969) 14-22.
3. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A. and Freeman, B.A., Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide, Proc. Natl. Acad. Sci. USA, 87 (1990) 1620-1624.
4. Bernatowicz. A., Ködel, U., Frei, K., Fontana, A. and Pfister, H.-W., Production of nitrite by primary rat astrocytes in response to pneumococci, J. Neuroimmunol., 60 (1995) 53-61.
5. Bö, L., Dawson, T.M., Wesselingh, S., Mörk, S., Choi, S., Kong, P.A., Hanley, D. and Trapp, B.D., Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains, Ann. Neurol., 36 (1994) 778-786.
6. Boje, K.M.K., Cerebrovascular permeability changes during experimental meningitis in the rat, J. Pharmacol. Exp. Ther., 274 (1995) 1199-1203.
7. Boje, K.M.K., Inhibition of nitric oxide synthesis partially attenuates alterations in the blood-cerebrospinal fluid barrier during experimental meningitis in the rat, Eur. J. Pharmacol., 272 (1995) 297-300.
8. Boje, K.M. and Arora, P., Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death, Brain Res., 587 (1992) 250-256.
9. Bredt, D.S. and Snyder, S.H., Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum, Proc. Natl. Acad. Sci. USA, 86 (1989) 9030-9033.
10. Bredt, D.S. and Snyder, S.H., Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme, Proc. Natl. Acad. Sci. USA. 87 (1990) 682-685.
11. Bredt, D.S., Ferris, C.D. and Snyder, S.H., Nitric oxide synthase regulatory sites: phosphorylation by cyclic AMP dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites, J. Biol. Chem., 267 (1992) 10976-10981.
12. Bredt, D.S., Hwang, P.M., Glatt, C.E., Lowenstein, C., Reed, R.R. and Snyder, S.H., Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase, Nature, 352 (1991) 714-718.
13. Brosnan, C.F., Cannella, B., Battistini, L. and Rane, C.S., Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species, Neurology, 45 (1995) S16-S21.
14. Campbell, I.L., Samimi A. and Chiang C.S., Expression of the inducible nitric oxide synthase: Correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis, J. Immunol., 153 (1994) 3622-3629.
15. Corbett, J.A., Tilton, R.G. Chang, K., Hasan, K.S., Ido, Y., Wang, J.L., Sweetland, M.A., Lancaster, J.R., Williamson, J.R. and McDaniel, M.L., Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction, Diabetes, 41 (1992) 552-556.
16. Cross, A.H., Misko, T.P., Lin, R.F., Mickey, W.F., Trotter, J.L. and Tilton, R.G., Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis is SJL mice, J. Clin. Invest., 93 (1994) 2684-2690.
17. Dawson, T.M. and Dawson, V.L., Nitric oxide: Actions and pathological roles, Neuroscientist, 1 (1995) 7-18.
18. Ding, A., Nathan, C.F., Graycar, J., Dernyck, R., Stuehr, D.J. and Srimal, S., Macrophage deactivating factor and transforming growth factors -β1, -β2 and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ, J. Immunol., 145 (1990) 940-944.
19. 131) volumes of rats determined by liquid nitrogen freezing, Circ. Res., 4 (1956) 419-424.
20. Garthwaite, J., Charles, S.L. and Chess-Williams, R., Endotheliumderived relaxing factor on activation of NMDA receptors suggests role as intercellular messenger in the brain, Nature, 336 (1988) 385-388.
21. Greenwood J., Mechanisms of blood-brain barrier breakdown, Neuroradiology, 33 (1991) 95-100.
22. Griffiths, M.J.D., Messent, M., MacAllister, R.J. and Evans, T.W. Aminoguanidine selectively inhibits inducible nitric oxide synthase, Br. J. Pharmacol., 110 (1993) 963-968.
23. Haberl, R.L., Anneser, F., Ködel, U., Pfister, H.W., Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis?, Neurol. Res., 16 (1994) 108-112.
24. Hauschildt, S., Bassenge, E., Bessler, W., Busse, R. and Mülsch, A., L-arginine-dependent nitric oxide formation and nitrite release in bone marrow-derived macrophages stimulated with bacterial lipopeptide and lipopolysaccharide, Immunology, 70 (1990) 332-337.
25. Hooper, D.C., Ohnishi, S.T., Kean, R., Numagami, Y., Dietzschold, B. and Koprowski, H., Local nitric oxide production in viral and autoimmune diseases of the central nervous system, Proc. Natl. Acad. Sci. USA, 92 (1995) 5312-5316.
26. Ikeda, M., Sato, I., Matsunaga, T., Takahashi, M., Yuasa, T. and Murota, S., Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and guillaine-barre syndrome, Intern. Med., 34 (1995) 734-737.
27. Jangro, D., West, G.A., Nguygen, T.-S. and Winn, H.R., Regulation of blood-brain barrier endothelial cells by nitric oxide, Circ. Res., 75 (1994) 528-538.
28. Jenkins, D.C., Charles, I.G., Thomsen, L.L., Moss, D.W., Holmes, L.S., Baylis, S.A., Rhodes P., Westmore, K., Emson, P.C. and Moncada, S., Roles of nitric oxide in tumor growth, Proc. Natl. Acad. Sci. USA, 92 (1995) 4392-4396.
29. Johnson, A.W., Land, J.M., Thompson, E.J., Bolanos, J.P., Clark, J.B. and Heales, S.J., Evidence for increased nitric oxide production in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 58 (1995) 107.
30. Kilbourn, R.G. and Belloni, P., Endothelial cell production of nitrogen oxides in response to interferon-γ in combination with tumor necrosis factor, interleukin-1 or endotoxin, J. Natl. Cancer Inst., 82 (1990) 772-776.
31. Koedel, U., Bernatowicz, A., Paul, R., Frei, K., Fontana, A. and Pfister, H.W., Experimental pneumococcal meningitis: Cerebrovascular alterations, brain edema and meningeal inflammation are linked to the production of nitric oxide, Ann. Neurol., 37 (1995) 313-323.
32. Korytko, P.J. and Boje, K.M.K., Pharmacological characterization of nitric oxide production during experimental meningitis in the rat, Neuropharmacology, 35 (1996) 231-237.
33. Kubes, P. and Granger, N.D. Editorial comment, Stroke, 23 (1992) 1124.
34. Lee, S.C., Dickson, D.W., Liu, W. Brosnan, C.F., Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-γ, J. Neuroimmunol., 46 (1993) 19-24.
35. Lee, S.C., Dickson, D.W., Brosnan, C.F. and Casadevall, A., Human astrocytes inhibit Cryptococcus Neoformans growth by a nitric oxide-mediated mechanism, J. Exp. Med., 180 (1994) 365-369.
36. Lei, S.Z., Pan, Z.H., Aggarwal, S.K., Chen, H.S., Hartman, J., Sucher, N.J. and Lipton, S.A., Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex, Neuron, 8 (1992) 1087-1099.
37. Lonchampt, M.O., Auguet, M., Delaflotte, S., Goulin-Schulz, J., Chabrier, P.E. and Braquet, P., Lipoteichoic acid: a new inducer of nitric oxide synthase, J. Cardiovasc. Pharmacol., 20 (1992) S145-S147.
38. MacMicking, J.D., Willenborg, D.O., Wedemann, M.J., Rockett, K.A. and Cowden, W.B., Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: Enhancement by the soluble products of encephalitogenic T cells, J. Exp. Med., 176 (1992) 303-307.
39. Manzoni, O., Prezeau, L., Marin, P., Deshager, S., Bockaert, J. and Fagni, L., Nitric oxide-induced blockade of NMDA receptors, Neuron, 8 (1992) 653-662.
40. Mayhan, W.G., Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension, Brain Res., 686 (1995) 99-103.
41. Meda, L., Cassatell, M.A., Szendrel, G.I., Otovos, L. Jr., Baron. P., Villalba, M., Ferrari, D. and Rossi, F., Activation of microglial cells by β-amyloid protein and interferon-γ, Nature, 374 (1995) 647-650.
42. Milstien, S., Sakai, N., Brew, B.J., Krieger, C., Vickers, J.H., Saito, K. and Heyes, M.P., Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases, J. Neurochem., 63 (1994) 1178-1180.
43. Misko, T.P., Moore, W.M., Kasten, T.P., Nickols, G.A., Corbett, J.A., Tilton, R.G., McDaniel, M.L., Williamson, J.R. and Currie, M.G, Selective inhibition of the inducible nitric oxide synthase by aminoguanidine, Eur. J. Pharmacol., 233 (1993) 119-125.
44. Montague, P.R., Gancayco, C.D., Winn, M.J., Marchase, R.B. and Friedlander, M.J., Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex, Science, 263 (1994) 973-977.
45. Nathan, C., Nitric oxide as a secretory product of mammalian cells, FASEB J., 6 (1992) 3051-3064.
46. Nowicki, J.P., Duval, D., Poignet, H. and Scatton, B., Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse, Eur. J. Pharmacol., 204 (1991) 339-340.
47. Peunova, N. and Enikolopov, G., Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells, Nature, 375 (1995) 68-73.
48. Pfister, H.-W., Bernatowicz, A., Ködel, U. and Wick, M., Nitric oxide production in bacterial meningitis, Neurol. Neurosurg. Psychiat., 58, (1995) 384-385.
49. Pfister, H.-W., Fontana, A., Täuber, M.G., Tomasz, A. and Scheld, W.M., Mechanisms of brain injury in bacterial meningitis: Workshop summary, Clin. Infect. Dis., 19 (1994) 463-479.
50. Pfister, H.-W., Koedel, U., Haberl, R.L., Dirnagl, U., Feiden, W., Ruckdeschel, G. and Einhäupl, K.M., Microvascular changes during the early phase of experimental bacterial meningitis, J. Cereb. Blood Flow Metab., 10 (1990) 914-922.
51. Pfister, H.-W., Frei, K., Ottnad, B., Koedel, U. Tomasz, T. and Fontana, A., Transforming growth factor β2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor α-independent early phase of experimental pneumococcal meningitis, J. Exp. Med., 176 (1992) 265-268.
52. Poser, C.M., Notes on the pathogenesis of multiple sclerosis, Clin. Neurosci., 1 (1994) 258-265.
53. Power, C. and Johnson, R.T., HIV-1 associated dementia: Clinical features and pathogenesis, Can. J. Neurol. Sci., 22 (1995) 92-100.
54. Prado, R., Watson, B.D., Kuluz, J. and Dietrich, W.D., Endothelium-derived nitric oxide synthase inhibition: Effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats, Stroke, 23 (1992) 1118-1124.
55. Radi, R., Beckman, J.S., Bush, K.M. and Freeman, B.A., Peroxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide, J. Biol. Chem., 266 (1991) 4244-4250.
56. Rapoport, S.I., Fredericks, W.R., Ohno, K. and Pettigrew, K.D., Quantitative aspects of reversible osmotic opening of the blood-brain barrier, Am J. Physiol., 238 (1980) R421-R431.
57. Rettori, V., Belova, N., Dees, W.L., Nyberg, C.L., Gimeno, M. and McCann, S.M., Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro, Proc. Natl. Acad. Sci. USA, 90 (1993) 10130-10134.
58. Rogers, S.W., Andrews, P.I., Gahring, L.C., Whisenand, T., Cauley, K., Crain, B., Hughes, T.E., Heinemann, S.F. and McNamara, J.O., Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis, Science, 265 (1994) 648-651.
59. Rosenkranz-Weiss, P., Sessa, W.C., Milstein, S., Kaufman, S., Watson, C.A., Pober, J.S., Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobioptern levels enhance endothelial nitric oxide synthase specific activity, J. Clin. Invest., 93 (1994) 2236-2243.
60. Schuman, E.M. and Madison, D.V., A requirement for the intercellular messenger nitric oxide in long-term potentiation, Science, 254 (1991) 1503-1506.
61. Skaper, S.D., Facci, L. and Leon, A., Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway, J. Neurochem., 64 (1995) 266-276.
62. Smith, Q.R., Ziylan, Y.Z., Robinson, P.J. and Rapoport, S.I., Kinetics and distribution volumes for tracers of different sizes in the brain plasma space, Brain Res., 462 (1988) 1-9.
63. Smith, Q.R., Quantitation of blood-brain barrier permeability. In E.A. Newell (Ed.), Implications of the Blood-Brain Barrier and Its Manipulation, Vol. 1 Plenum Medical Book Co., New York, 1989, pp. 85-118.
64. Stewart, D.J., A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors, J. Neuro-Oncol., 20 (1994) 121-139.
65. Stone, L.A., Smith, M.E., Albert, P.S., Bash, C.N., Maloni, H., Frank, J.A., McFarland, H.F., Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age, Neurology, 45 (1995) 1122-1126.
66. Syrogiannopoulos, G.A., Hansen, E.J., Erwin, A.L., Munford, R.S., Rutledge, J., Reisch, J.S. and McCracken, G.H. Jr., Haemophilus influenzas, type b lipooligosaccharide induces meningeal inflammation, J. Infect. Dis., 157 (1988) 237-244.
67. Tatro, J.B., Romero, L.I., Beasley, D., Steere, A.C. and Reichlin, S., Borrelia burgdorferi, and Escherichia coli, lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat cells, J. Infect. Dis., 169 (1994) 1014-1022.
68. Tunkel, A.R. and Scheld, W.M., Pathogenesis and pathophysiology of bacterial meningitis. Annu. Rev. Med., 44 (1993) 103-120.
69. Tureen, J., Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: Role of nitric oxide, J. Clin. Invest., 95 (1995) 1086-1091.
70. Visser, J.J., Scholten, R.J.P.M. and Hoekman, K., Nitric oxide synthesis in meningococcal meningitis, Ann. Intern. Med., 120 (1994) 345-346.
71. Vodovotz, Y., Bogdan, C., Paik, J. Xie, Q.-W. and Nathan, C., Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β, J. Exp. Med., 178 (1993) 605-613.
72. Wispelwey, B., Lesse, A.J., Hansen, E.J. and Scheld, W.M., Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat, J. Clin. Invest., 82 (1988) 1339-1346.
73. Wolff, D.J. and Lubeskie, A., Aminoguanidine is an isotbrm-selective, mechanism-based inactivator of nitric oxide synthase, Arch. Biochem. Biophys., 316 (1995) 290-301.
74. Zar, J.H. (Ed.), Ch. 18, Comparing simple linear regression equations. Biostatistical Analysis, Prentice-Hall Inc., Englewood Cliffs, New Jersey, 1984, pp. 292-305.
75. Zhang, J., Benveniste, H., Klitzman, B., Piantadosi, C.A., Nitric oxide synthase inhibition and extracellular glutamate concentration after cerebral ischemia/reperfusion, Stroke, 26 (1995) 298-304.
76. Zhuo, M., Small, S.A., Kandel, E.R. and Hawkins, R.D., Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus, Science, 260 (1993) 1946-1950.